Core Laboratories (CLB) EBT (2022 - 2026)

Core Laboratories' EBT history runs 5 years deep, the most recent figure standing at -$1.0 million for Q1 2026.

• On a quarterly basis, EBT fell 155.32% year-over-year to -$1.0 million in Q1 2026; TTM through Mar 2026 was $43.1 million, a 0.52% increase from a year earlier, with the FY2025 full-year figure at $45.9 million, down 0.63% from the prior year.
• EBT declined to -$1.0 million in Q1 2026 per CLB's latest filing, from $13.2 million in the prior quarter.
• Across five years, EBT topped out at $18.3 million in Q3 2025 and bottomed at -$1.0 million in Q1 2026.
• The 5-year median for EBT is $11.5 million (2023), against an average of $10.3 million.
• Across the five-year window, EBT jumped 75.18% in 2023 and slumped 155.32% in 2026, its largest moves.
• Year by year, EBT stood at $12.5 million in 2022, then fell by 12.55% to $11.0 million in 2023, then climbed by 5.31% to $11.5 million in 2024, then rose by 14.53% to $13.2 million in 2025, then plunged by 107.59% to -$1.0 million in 2026.
• Per Business Quant, the three latest CLB EBT figures stand at -$1.0 million (Q1 2026), $13.2 million (Q4 2025), and $18.3 million (Q3 2025).